Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
100%.
The French are still relatively skinny for exactly that reason; the food is in general much less processed and the rules are very strict. As a North American who lives there, I’ve lost weight just by being here.